feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / The Wild West of Female Testosterone Therapy

The Wild West of Female Testosterone Therapy

27 Jan

•

Summary

  • FDA-approved testosterone for women has been unavailable since 2004.
  • Women are increasingly seeking off-label testosterone for energy and mood.
  • Navigating female testosterone therapy involves risks and an unregulated market.
The Wild West of Female Testosterone Therapy

A 2004 FDA panel unanimously voted against authorizing Procter & Gamble's testosterone patch Intrinsa for women, citing insufficient long-term safety data. This decision left a void for decades, with no testosterone products approved for female use in the U.S. In recent years, however, there's a growing interest among Gen X and millennial women in testosterone, not just for libido but for overall vitality, claiming benefits like increased energy and mental clarity.

This resurgence has led to a complex and often unregulated landscape, dubbed the 'Wild West' of female testosterone therapy. While some medical practitioners are cautiously exploring its use, many women are navigating this space through compounding pharmacies and online clinics. The lack of FDA-approved formulations and clear dosing guidelines creates challenges, with risks of improper management and potential side effects becoming a significant concern for patients and experts alike.

trending

Al Kholood vs Al Nassr

trending

Lakers vs Wizards odds

trending

Ruturaj Gaikwad celebrates birthday

trending

Maghi Purnima bathing festival

trending

Benzema refuses to play

trending

Giants face Mumbai Indians

trending

realme P4 Power 5G launched

trending

TNTET 2025 result announced

trending

Gold silver prices today

Historically viewed as a male hormone, testosterone is vital for women's health, playing roles in reproductive health, bone density, and mood. While research continues, current FDA guidelines do not support testosterone therapy for general menopausal symptoms. The path toward an approved product for women remains uncertain, facing significant regulatory hurdles and high development costs, leaving many women to navigate this gray area with limited support.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
An FDA panel voted against authorizing the first testosterone patch for women in 2004 due to insufficient long-term safety data, and no product has been approved since.
Women are increasingly seeking testosterone for benefits beyond libido, including improved energy, mood, and overall vitality.
The lack of FDA-approved formulations and clear dosing guidelines creates a complex and unregulated market, leading to potential risks of improper management and side effects.

Read more news on

Healthside-arrow

You may also like

GLP-1 Drugs: Diet Industry's New Cash Cow?

18 Jan • 66 reads

article image

Beige Fat Loss Linked to Skyrocketing Blood Pressure

16 Jan • 48 reads

article image

Obesity Pill: Cheaper, Needle-Free Future for UK?

15 Jan • 102 reads

article image

New Triple-Action Drug Promises Major Weight Loss

12 Jan • 96 reads

article image

Lilly Drug Combo Fights Arthritis & Obesity

9 Jan • 107 reads

article image